Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
BUZZ-Revolution Medicines shares rise as new pancreatic cancer clinical trial data shows sustained efficacy

BUZZ-Revolution Medicines shares rise as new pancreatic cancer clinical trial data shows sustained efficacy

路透社路透社2026/11/20 13:25
Show original

- ** Revolution Medicines (RVMD.O) shares rose 3.4% in pre-market trading to $164.98

** RVMD said on Thursday (link) that its FDA-approved drug Rasonque, in combination with standard chemotherapy, successfully shrank tumors and delayed disease progression in an early- to mid-stage study of patients with metastatic pancreatic cancer

** The study enrolled 61 patients who received Rasonque (also known as daraxonrasib) in combination with gemcitabine and nab-paclitaxel

** After a median follow-up of 18.3 months, 60.7% of patients experienced tumor shrinkage, with tumors becoming undetectable in 8.2% of patients

** The median survival for patients was 12.8 months before disease progression or death. The company estimates that 76.6% of patients were still alive one year after starting treatment

**ERAS said its rival Erasca (ERAS.O) developed an oral anti-cancer drug that shrank tumors in many patients with advanced pancreatic and lung cancer in an early clinical trial ((link))

** As of the close of the previous trading day, RVMD shares have doubled this year


(To assist non-native English speakers, Reuters provides its reports in automated translations into several other languages. As automated translations may contain errors or lack intended context, Reuters does not guarantee the accuracy of the translated text and provides it solely for reader convenience. Reuters accepts no responsibility for any loss or damage arising from the use of automated translation functions.)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!